ACADIA PHARMACEUTICALS ($ACAD) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of $0.11 per share, missing estimates of $0.11 by $0.00. The company also reported revenue of $244,320,000, beating estimates of $244,123,515 by $196,485.
You can see Quiver Quantitative's $ACAD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ACADIA PHARMACEUTICALS Insider Trading Activity
ACADIA PHARMACEUTICALS insiders have traded $ACAD stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $ACAD stock by insiders over the last 6 months:
- MARK C. SCHNEYER (EVP, CHIEF FINANCIAL OFFICER) has made 0 purchases and 5 sales selling 20,409 shares for an estimated $333,151.
- BRENDAN TEEHAN (EVP, COO, HEAD OF COMMERCIAL) sold 10,329 shares for an estimated $173,630
- JAMES KIHARA (PRINCIPAL ACCOUNTING OFFICER) has made 0 purchases and 5 sales selling 7,998 shares for an estimated $131,227.
- ELIZABETH A. GAROFALO sold 4,919 shares for an estimated $89,673
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ACADIA PHARMACEUTICALS Hedge Fund Activity
We have seen 173 institutional investors add shares of ACADIA PHARMACEUTICALS stock to their portfolio, and 107 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 8,636,698 shares (+67.8%) to their portfolio in Q1 2025, for an estimated $143,455,553
- MORGAN STANLEY added 5,621,195 shares (+335.4%) to their portfolio in Q4 2024, for an estimated $103,148,928
- RTW INVESTMENTS, LP removed 5,002,005 shares (-36.5%) from their portfolio in Q4 2024, for an estimated $91,786,791
- ASSENAGON ASSET MANAGEMENT S.A. added 3,663,145 shares (+inf%) to their portfolio in Q1 2025, for an estimated $60,844,838
- SG AMERICAS SECURITIES, LLC removed 2,465,581 shares (-99.3%) from their portfolio in Q1 2025, for an estimated $40,953,300
- POINT72 ASSET MANAGEMENT, L.P. added 2,230,815 shares (+inf%) to their portfolio in Q4 2024, for an estimated $40,935,455
- CITIGROUP INC added 1,547,641 shares (+1288.3%) to their portfolio in Q4 2024, for an estimated $28,399,212
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ACADIA PHARMACEUTICALS Price Targets
Multiple analysts have issued price targets for $ACAD recently. We have seen 2 analysts offer price targets for $ACAD in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- An analyst from UBS set a target price of $22.0 on 04/28/2025
- Yatin Suneja from Guggenheim set a target price of $20.0 on 01/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
